Effects of Combination Treatment with Leptin and Liraglutide on Glucose Metabolism in Insulin-Dependent Diabetic Mice
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26104595 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Linlin Fu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Research Center of Health, Physical Fitness and Sports, Nagoya University, Fro-cho, Chikusa-ku, Nagoya 464-8601, Aichi, Japan. Hauptthemen laut MEDLINE: Liraglutide, Leptin, Diabetes Mellitus, Experimental, Hypoglycemic Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: a Grant-in Aid for Scientific Research (C) from the Japanese Society for Promotion of Science, JST SPRING, a grant from the Japan IDDM Network.
Abstract (Originalsprache)
We investigated whether the peripheral co-administration of leptin and liraglutide (a glucagon-like peptide-1 receptor agonist) improved glucose metabolism in a mouse model of insulin-dependent diabetes mellitus (IDDM). Twelve-week-old male C57BL/6J mice were injected intraperitoneally with a high dose of streptozotocin to induce IDDM or vehicle-treated. Mice with IDDM were divided into four groups: leptin treatment alone (LEP), liraglutide treatment alone (LIRA), co-administration of leptin and liraglutide treatment (LEP+LIRA), untreated mice (UNT). Vehicle-treated mice were the healthy controls (HC). The blood glucose (BG) levels were measured, and a glucose tolerance test (GTT) was performed to compare the five groups. Leptin was administered peripherally at 20 μg/day using an osmotic pump, while liraglutide was administered subcutaneously at 1000 μg/kg/day. Monotherapy with leptin or liraglutide significantly improved glucose metabolism, as assessed by comparing BG levels and GTTs with those of the UNT group. Mice in the LEP+LIRA group showed even greater improvements in glucose metabolism than the monotherapy groups. Notably, glucose metabolism in the LEP+LIRA group improved comparably with the HC group. Thus, the peripheral co-administration of leptin and liraglutide effectively improved glucose metabolism in mice with IDDM without the use of insulin.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Center of Health, Physical Fitness and Sports, Nagoya University, Fro-cho, Chikusa-ku, Nagoya 464-8601, Aichi, Japan.
- Department of Endocrinology and Diabetes, Graduate School of Medicine, Nagoya University, 65 Tsurumai-Cho, Showa-ku, Nagoya 466-8560, Aichi, Japan.
- Department of Endocrinology and Diabetology, Nagoya City University East Medical Center, 1-2-23 Wakamizu, Chikusa-ku, Nagoya 464-8547, Aichi, Japan.
ORCID-Profile: Mariko Sugiyama, Shahriar Kamal, Teruhiko Koike, Hiroshi Arima
Förderung
- a Grant-in Aid for Scientific Research (C) from the Japanese Society for Promotion of Science
- JST SPRING
- a grant from the Japan IDDM Network
- Japanese Society for Promotion of Science
- Japan IDDM Network
Zitieren
APA
Fu, L., Sugiyama, M., Kamal, S., Ide, T., Takeda, T., Kuno, M., Takagi, H., Koike, T., Arima, H., & Banno, R. (2025). Effects of Combination Treatment with Leptin and Liraglutide on Glucose Metabolism in Insulin-Dependent Diabetic Mice. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26104595
Vancouver
Fu L, Sugiyama M, Kamal S, Ide T, Takeda T, Kuno M, et al. Effects of Combination Treatment with Leptin and Liraglutide on Glucose Metabolism in Insulin-Dependent Diabetic Mice. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26104595
BibTeX
@article{Fu2025,
author = {Fu, Linlin and Sugiyama, Mariko and Kamal, Shahriar and Ide, Tsubasa and Takeda, Tadashi and Kuno, Mitsuhiro and Takagi, Hiroshi and Koike, Teruhiko and Arima, Hiroshi and Banno, Ryoichi},
title = {Effects of Combination Treatment with Leptin and Liraglutide on Glucose Metabolism in Insulin-Dependent Diabetic Mice},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26104595}
}
EUVIMED